H
Harvest
Tax-loss replacement research
PTGX
Protagonist Therapeutics, Inc.
Health CareBiotechnologyBiotechnology
28 stocks · 12 ETFs
data as of Aug 24, 2026
REPLACEMENT RESEARCH

Tax-loss harvesting alternatives for PTGX

Among the 28 Biotechnology peers screened, XNCR (Xencor Inc) has tracked PTGX most closely over the past year, with a return correlation of 0.30. The strongest fund stand-in is XBI (SPDR S&P Biotech ETF) at 0.44 over the past year. Correlations are computed from daily closing-price returns aligned by trading day.

Run this search live in the Screener →
STOCKS

Single-name peers

TickerNameSub-industry1Y3Y5Y10Y
XNCRXencor IncBiotechnology0.300.290.220.21
VIRVir Biotechnology, Inc.Biotechnology0.290.230.190.11
ROIVRoivant SciencesBiotechnology0.280.280.22
REGNRegeneron PharmaceuticalsBiotechnology0.250.250.170.13
NBIXNeurocrine BiosciencesBiotechnology0.250.170.140.12
TGTXTG Therapeutics, Inc.Biotechnology0.210.250.250.18
LGNDLigand Pharmaceuticals, Inc.Biotechnology0.210.200.200.14
RCUSArcus Biosciences, Inc.Biotechnology0.200.280.220.15
EXELExelixisBiotechnology0.200.180.180.16
KRYSKrystal BiotechBiotechnology0.200.280.170.16
SRPTSarepta TherapeuticsBiotechnology0.180.140.100.11
HRMYHarmony Biosciences Holdings, Inc.Biotechnology0.180.170.16
ARWRArrowhead PharmaceuticalsBiotechnology0.180.190.230.14
VRTXVertex PharmaceuticalsBiotechnology0.160.190.140.13
BMRNBioMarin PharmaceuticalBiotechnology0.160.160.160.14
INCYIncyteBiotechnology0.160.180.130.11
CYTKCytokineticsBiotechnology0.150.170.180.16
GILDGilead SciencesBiotechnology0.140.160.130.10
AMGNAmgen Inc.Biotechnology0.130.190.090.10
ADMAADMA Biologics, Inc.Biotechnology0.120.200.170.13
UTHRUnited TherapeuticsBiotechnology0.110.100.080.11
HALOHalozymeBiotechnology0.110.180.160.16
BIIBBiogen Inc.Biotechnology0.090.180.160.11
VCELVericelBiotechnology0.070.180.200.15
RGENRepligenBiotechnology0.070.060.120.12
ALNYAlnylam PharmaceuticalsBiotechnology0.060.110.150.13
MRNAModerna Inc.Biotechnology0.050.090.110.08
FTREFortreaBiotechnology0.030.060.04
ETFS

Fund stand-ins

An ETF is generally not 'substantially identical' to a single stock, which is why funds are the standard wash-sale-aware replacement.

TickerNameFocusMatch1Y3Y5Y10Y
XBISPDR S&P Biotech ETFBiotechnology (Equal Wt)INDUSTRY0.440.440.380.30
IBBiShares Biotechnology ETFBiotechnologyINDUSTRY0.360.370.320.26
XPHSPDR S&P PharmaceuticalsPharmaceuticals (Equal Wt)INDUSTRY0.360.340.290.25
IHEiShares US Pharmaceuticals ETFPharmaceuticalsINDUSTRY0.280.280.210.21
FHLCFidelity MSCI Health Care ETFHealth Care SectorSECTOR0.230.260.220.20
VHTVanguard Health Care ETFHealth Care SectorSECTOR0.230.260.220.21
PPHVanEck Pharma ETFPharmaceuticalsINDUSTRY0.210.210.190.19
ARKGARK Genomic Revolution ETFGenomics (Active)INDUSTRY0.200.270.270.25
IYHiShares US Healthcare ETFHealth Care SectorSECTOR0.190.230.200.19
XLVHealth Care Select Sector SPDRHealth Care SectorSECTOR0.190.230.180.18
IHFiShares Health Care ProvidersHealth Care ProvidersINDUSTRY0.090.110.130.17
IHIiShares Medical Devices ETFMedical DevicesSUB-IND0.040.130.170.17
NEXT STEPS

Harvesting a loss in PTGX?

RELATED

Replacement research for PTGX's peers

Browse all tickers →

Method: Pearson correlation of daily closing-price returns, Yahoo Finance data, series aligned by trading day, refreshed weekly. A cell is blank when overlapping history covers less than 60% of its window. Correlation is descriptive, not predictive. Wash-sale treatment depends on facts and circumstances — confirm with a tax professional. Not investment advice.